Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

about

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

P2860

Q45873810-372BC80F-EBB8-4413-A796-F4E0CC6E7865

P2860

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Item

http://www.wikidata.org/entity/Q48046381

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

@en

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

@nl

type

Item

label

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

@en

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

@nl

prefLabel

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

@en

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

@nl

P1476

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration

@en

P2093

D Aryal

http://www.w3.org/2001/XMLSchema#string

D Hamilton

http://www.w3.org/2001/XMLSchema#string

P Maiti

http://www.w3.org/2001/XMLSchema#string

S C Fowler

http://www.w3.org/2001/XMLSchema#string

W C Wetsel

http://www.w3.org/2001/XMLSchema#string

Y Akkhawattanangkul

http://www.w3.org/2001/XMLSchema#string

Y Xue

http://www.w3.org/2001/XMLSchema#string

P2860

Systems analysis of genetic variation in MPTP neurotoxicity in mice

Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference

Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.

Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment

A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder

Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations

Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis

Motor and associative deficits in D2 dopamine receptor knockout mice

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice

P304

522-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/GBB.12377

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. McDonald

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28239983

http://www.w3.org/2001/XMLSchema#string

P932

5543812

http://www.w3.org/2001/XMLSchema#string

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

about

P2860

P2860

Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932